Literature DB >> 1672169

CD4 T-lymphocyte counts and Pneumocystis carinii pneumonia in pediatric HIV infection.

A Kovacs1, T Frederick, J Church, A Eller, M Oxtoby, L Mascola.   

Abstract

The relationship between CD4 T-lymphocyte counts and infection with the human immunodeficiency virus (HIV) is retrospectively investigated for 266 HIV-infected and uninfected children who were born to infected women, including 39 with Pneumocystis carinii pneumonia (PCP), in a population-based surveillance study. Of 21 perinatally HIV-infected children with PCP only 10 (48%) had CD4 T-lymphocyte counts that were less than 500 x 10(6) cells/L (500 cells/mm3), compared with all 18 who were infected via blood transfusions or clotting factors. Among 68 children who were 1 year or younger, 18 (90%) of 20 PCP cases had CD4 T-lymphocyte counts that were less than 1500 x 10(6) cells/L (1500 cells/mm3) compared with only five (10%) of 48 children who did not have the acquired immunodeficiency syndrome (odds ratio, 77.4; 95% confidence interval, 19.7 to 313.4). The mean CD4 T-lymphocyte count was lower for the 39 PCP cases when compared with the 188 children who were at different stages of HIV infection and did not have the acquired immunodeficiency syndrome (AIDS) independent of age. The majority of perinatally HIV-infected children with PCP were 6 months or younger and 50% were previously unknown to be infected. Thus, HIV-positive children should be identified early and followed closely. CD4 T-lymphocyte counts may be useful in monitoring HIV-positive children and determining when to begin PCP prophylaxis.

Entities:  

Mesh:

Year:  1991        PMID: 1672169

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  11 in total

1.  Pneumocystis prophylaxis for all, some, or no HIV-infected infants less than one year of age: A decision analysis approach.

Authors:  U D Allen; S E Read
Journal:  Can J Infect Dis       Date:  1993-11

Review 2.  Management of antiretroviral therapy in neonates, children, and adolescents.

Authors:  Michael Neely; Andrea Kovacs
Journal:  Curr HIV/AIDS Rep       Date:  2004-06       Impact factor: 5.071

Review 3.  Pediatric human immunodeficiency virus infection.

Authors:  J B Domachowske
Journal:  Clin Microbiol Rev       Date:  1996-10       Impact factor: 26.132

4.  The pediatric pulmonary and cardiovascular complications of vertically transmitted human immunodeficiency virus (P2C2 HIV) infection study: design and methods. The P2C2 HIV Study Group.

Authors: 
Journal:  J Clin Epidemiol       Date:  1996-11       Impact factor: 6.437

5.  Determination of CD4 and CD8 lymphocyte subsets by a new alternative fluorescence immunoassay.

Authors:  T N Denny; B D Jensen; E I Gavin; A G Louzao; F A Vella; J M Oleske; W Wong
Journal:  Clin Diagn Lab Immunol       Date:  1995-05

6.  Maturational changes in peripheral lymphocyte subsets pertinent to monitoring human immunodeficiency virus-infected Chinese pediatric patients.

Authors:  K M Kam; W L Leung; K H Wong; S S Lee; M Y Hung; M Y Kwok
Journal:  Clin Diagn Lab Immunol       Date:  2001-09

7.  Combined therapy in human immunodeficiency virus-infected children--a 4-year experience.

Authors:  T Güngör; M Funk; R Linde; I Kynast; A Allendorf; C Lotz; S Ehrenforth; D Hofmann; B Kornhuber; W Kreuz
Journal:  Eur J Pediatr       Date:  1993-08       Impact factor: 3.183

Review 8.  A Molecular Window into the Biology and Epidemiology of Pneumocystis spp.

Authors:  Liang Ma; Ousmane H Cissé; Joseph A Kovacs
Journal:  Clin Microbiol Rev       Date:  2018-06-13       Impact factor: 26.132

9.  CD4 T cell count as predictor of Pneumocystis carinii pneumonia in children born to mothers infected with HIV. European Collaborative Study Group.

Authors: 
Journal:  BMJ       Date:  1994-02-12

10.  Management of Antiretroviral Therapy in Neonates, Children, and Adolescents.

Authors:  Michael Neely; Andrea Kovacs
Journal:  Curr Infect Dis Rep       Date:  2003-12       Impact factor: 3.725

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.